Does a positive NECPAL score mean higher risk of dying for ICU patients aged 75 and older?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll patients aged 75 and older admitted to the ICU at CSAPG in Sant Pere de Ribes, Barcelona. At enrollment clinicians will record the NECPAL score and baseline clinical information without changing usual care. Participants will be followed for 90 days after ICU admission to capture mortality outcomes, excluding patients who die within the first 24 hours. The analysis will compare 90-day mortality between patients with a positive NECPAL and those without to see if the score predicts higher risk.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who meet all of the following inclusion criteria may be included in the study:
* Men and women aged 75 years or older.
* Admission to the ICU of the study center.
* Legal capacity to provide informed consent.
* Signed informed consent for study inclusion, either by the participant or their legal representative.

Exclusion Criteria:

Participants who meet any of the following exclusion criteria may not be included in the study:

-Death within the first 24 hours of ICU admission.

Where it's running

• Csapg
  Sant Pere de Ribes, Barcelona, Spain Recruiting

Study contacts

• Principal investigator: Diana Gutiérrez, MD — Csapg
• Study coordinator: Diana Gutiérrez, MD
• Email: dpgutierrez@csapg.cat
• Phone: +34938960025

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home-based Acute Care for Older Adults Initiated by Emergency Services

  A team-based, home-delivered acute care approach for people 75+ is being studied to see if it can match the results of usual ED care in terms of care needs and mortality.

  Recruiting Vastra Gotaland Region · Gothenburg · NCT07472335

• Observational study on Vitamin C Injektopas® for vitamin C deficiency

  This study is testing how well Vitamin C Injektopas® helps people with vitamin C deficiency feel better over time and if they can handle the treatment.

  Recruiting Pascoe Pharmazeutische Praeparate GmbH · Vienna, Etc., Austria · NCT06983847

• Using Tenecteplase after Mechanical Thrombectomy for Stroke

  This study is testing if adding a drug called Tenecteplase after a procedure to remove a blood clot can help people who have had a stroke feel better and recover more effectively.

  Recruiting Phase 2/3 ProMedica Health System · Toledo, Ohio · NCT06949228

• Evaluation of a program to provide care in aged care homes in rural Australia

  This study is testing a new program to see if providing better care in rural aged care homes can help keep residents from needing to go to the hospital.

  Recruiting at 8 sites Monash University · Ararat, Victoria and 7 other locations · NCT06901167

• Using the medidux smartphone app to manage discharge from the Acute Admission Unit

  We will test whether adults discharged from the Acute Admission Unit with cough, back pain, or abdominal discomfort who use the medidux app are less likely to return or need extra medical visits within 7 days.

  Recruiting Mobile Health AG · Horgen, Canton of Zurich · NCT06655337

• A large biobank for acute and emergency medicine

  This study is collecting health information and samples from patients with sudden illnesses in the Emergency Department to see if it can help improve treatments and predict how patients will do.

  Recruiting University Medical Center Groningen · Groningen · NCT04615065

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.